Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v6-EN
Language English English
Date Updated 2020-07-14 2020-07-07
Drug Identification Number 02244550 02244550
Brand name PAMIDRONATE DISODIUM FOR INJECTION PAMIDRONATE DISODIUM FOR INJECTION
Common or Proper name Pamidronate Disodium for Injection Pamidronate Disodium for Injection
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients PAMIDRONATE DISODIUM PAMIDRONATE DISODIUM
Strength(s) 3MG 3MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 1 x 10mL 1 x 10mL
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-06-16 2020-06-16
Estimated end date 2020-07-13
Actual end date 2020-07-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Other presentations remain available.
Health Canada comments